Cigna Group CEO transition and guidance lift, shares react ahead of July change

By Christina Vogel, Background & Management desk. Reviewed prior to publication on 2026-06-30, 13:31.

Cigna Group (US1255231003) is approaching a leadership change at the top of the company in early July 2026. The NYSE-listed health insurer couples this transition with raised full-year earnings guidance after a series of quarterly beats.

Leadership change at the top

The board of Cigna Group has announced that long-serving chief executive David Cordani will retire from the CEO role in July 2026 and move to the position of executive chair of the board. His successor as CEO will be Brian Evanko, currently president and chief operating officer, with the change scheduled to take effect on July 1, 2026.

According to recent market commentary, Cordani and Evanko are set to work closely through the transition period to support continuity in operations and strategy. The leadership move comes at a time when major managed-care peers in the United States, such as UnitedHealth Group and Elevance Health, are also managing regulatory scrutiny and cost trends in their health insurance portfolios.

Guidance raised after another EPS beat

In its first-quarter 2026 update, Cigna Group reported adjusted earnings per share of 7.79 dollars. Analysts noted that this marked the fifth consecutive quarter in which the company delivered an EPS figure above consensus expectations, highlighting consistent profitability in its medical and pharmacy-benefit operations.

Alongside the Q1 figures, management raised full-year 2026 adjusted EPS guidance to at least 30.35 dollars per share. This higher floor for earnings targets was interpreted as a signal of confidence in the performance of the health services and insurance segments, even as the industry faces ongoing pressure from medical-cost inflation and reimbursement dynamics.

What the company sells

Cigna Group's core business lies in health insurance and related services, including commercial medical coverage, government-sponsored plans and a significant pharmacy-benefit and specialty pharmacy operation. The company also offers behavioral health support and wellness programs for employer clients and individuals.

Where the stock trades today

The Cigna Group shares (US1255231003) trade on the NYSE, with the latest verified price data indicating a level close to the high-200-dollar range as of 2026-06-29, 16:00 Eastern Time, in U.S. dollars.

Disclaimer: This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any security. All data are based on sources believed to be reliable as of the stated dates, but accuracy and completeness cannot be guaranteed.